ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,397,045, issued on Aug. 26, was assigned to IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE (London).
"Clostridioides difficile" was invented by Julian Marchesi (London), Julie Mcdonald (London) and Benjamin Mullish (London).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to Clostridioides difficile, and in particular to compounds, polypeptides and mixtures for the treatment of C. difficile infections. The invention also relates to nucleic acids, vectors comprising these nucleic acids and microorganisms for the treatment of C. difficile infections, and to methods of identifying and matching faecal microbiota transplant (FMT) don...